Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6325797

CC(C)(Oc1ccc(-c2nc(C(=O)Nc3ccc(N4CCOCC4)cc3)c(-c3ccc(Cl)cc3)s2)cc1)C(=O)O.O=C(O)C(F)(F)F

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARA Q07869 4/20 0.49
▸ PPARD Q03181 3/20 0.45
▸ DGAT1 O75907 3/20 0.44
▸ ADORA2A P29274 2/20 0.43
▸ MAPT P10636 2/20 0.43
▸ MAPK1 P28482 2/20 0.43
▸ NPC1 O15118 2/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ MITF O75030 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ TP53 P04637 1/20 0.43
▸ XBP1 P17861 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ UBE2N P61088 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ TLR9 Q9NR96 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ ABCB1 P08183 1/20 0.42
▸ MAPKAPK2 P49137 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6333105 0.94 DGAT1 (0.51) PPARADGAT1MAPTNPC1RAB9A
SCHEMBL6325803 0.91 ADORA2A (0.42) PPARADGAT1ADORA2AMAPTMAPK1
SCHEMBL6329127 0.87 PPARA (0.56) PPARAPPARDMAPTALDH1A1SMN1; SMN2
Trifluoroacetic Acid SCHEMBL6328364 0.86 DGAT1 (0.44) DGAT1MAPTMAPK1NPC1RAB9A
SCHEMBL6333109 0.85 DGAT1 (0.49) PPARADGAT1MAPTNPC1RAB9A
SCHEMBL6333235 0.84 PPARA (0.67) PPARAPPARDMAPT
SCHEMBL6325756 0.84 PPARA (0.54) PPARAPPARDMAPT
SCHEMBL6325562 0.83 PPARA (0.55) PPARAPPARDMAPTALDH1A1LMNA
SCHEMBL6329096 0.82 PPARA (0.56) PPARAPPARDMAPTALDH1A1SMN1; SMN2
Trifluoroacetic Acid SCHEMBL6332856 0.82 DGAT1 (0.43) PPARADGAT1MAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050014805-A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity BAYER PHARMACEUTICALS CORPORATION 2005-01-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014805-A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity GPR119, EGLN3, PC PPARA 49/4885PPARD 55/4885DGAT1 386/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback